4//SEC Filing
Hamel Lawrence G 4
Accession 0001209191-20-009164
CIK 0001427925other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:14 PM ET
Size
5.7 KB
Accession
0001209191-20-009164
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2020-02-11$1.71/sh−5,613$9,598→ 127,769 total
Holdings
- 29,795(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:14 PM ET
- Size
- 5.7 KB